 |
Articles: Regulatory Issues |
Takeda Receives FDA Complete Response Letter for Alogliptin, An Investigational Treatment for Type 2 Diabetes
Takeda Pharmaceuticals North America, 07/02/09
Prior Articles
Examination of the Relationship Between Oncology Drug Labeling Revision Frequency and FDA Product Categorization
American Journal of Public Health, 07/01/09
Roche Discontinues and Plans to Delist Accutane in the U.S.
Roche, 07/01/09
Free full text
New EU Committee Leaves Member States Out In The Cold
PharmExec, 07/01/09 Biopure Receives Notice of Nasdaq Delisting
BioPure, 07/01/09
Free full text
Novartis receives Complete Response letter from the US Food and Drug Administration for its investigational vaccine Menveo
Novartis, 07/01/09
Free full text
DFine Europe GmbH Accepts Terms of Preliminary Injuction Issued by German Court for Medtronic GmbH
Medtronic, 06/30/09
Free full text
Seretide: Irish patent litigation update
GlaxoSmithKline, 06/29/09
Free full text
FDA Tells Drug and Device Makers to Give Balanced Picture of Risks in Ads, Labels
JAMA, 06/29/09 Lundbeck receives FDA Complete Response Letter on Serdolect for the treatment of schizophrenia
Lundbeck, 06/26/09
Free full text
CEL-SCI Files Patent Application to Support Company's Treatment for More Virulent Strain of H1N1 Swine and Other Influenza Viruses
CEL-SCI, 06/26/09 eHealth Ontario CEO, Sarah Kramer, is terminated
Canadian Healthcare Technology, 06/26/09
Free full text
Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
Cell Therapeutics, 06/25/09
Free full text
Regulatory update for REZONIC (casopitant mesylate)
GlaxoSmithKline, 06/24/09
Free full text
Merck and Schering-Plough Receive Request for Additional Information from FTC Regarding Proposed Merger
Merck & Co., 06/23/09
Free full text
Biovail Announces Closing of Acquisition of Worldwide Rights to Tetrabenazine
BioVail Corporation, 06/23/09
Free full text
The Ups and Downs of the FDA Budget
BioPharm, 06/22/09
Free full text
Stiffer Enforcement at the FDA
BioPharm, 06/22/09
Free full text
Court Grants Teva Summary Judgment Of Non-Infringement On Eloxatin
Teva Pharmaceutical Industries, 06/19/09
Free full text
Oscient Pharmaceuticals Lays Off 180 Reps
PharmExec, 06/18/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: U.S.Pharmacist, FDA Drug Alerts, Pharmiweb
more...
|
247 Available Pages
|
|
